Bioline, The PCR Company, a wholly-owned subsidiary of Meridian
Bioscience, Inc. VIVO, is proud to announce the worldwide
release of the high performance ISOLATE II range of nucleic acid
purification kits.
Based on filter membrane spin column technology with simple
bind-wash-elute steps; the new Bioline ISOLATE II kits are designed for
fast and efficient isolation of DNA or RNA from a wide range of
biological materials. By using ISOLATE II kits, researchers can expect
higher yields, higher purity and greater reproducibility when compared
to previous generation nucleic acid purification kits.
Marco Calzavara, President of Bioline commented, “With ISOLATE II
nucleic acid purification kits, researchers can now quickly achieve
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in